BMP2 and occult macular dystrophy: Considering that the ubiquitin‐proteasome pathway is the primary route for protein degradation of short‐lived proteins,[26] we speculated that OMD might inhibit the degradation of BMP2 via disrupting the ubiquitin‐proteasome system.